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Human bocavirus was detected in 57 (18.3%) of 312
children with acute respiratory infection (ARI) who required
hospitalization in Jordan. It was also detected in 30 (21.7%)
of 138 children with severe ARI, in 27 (15.5%) of 174 with
mild or moderate disease, and in 41 (72%) of 57 with other
pathogens.
A
cute respiratory infection (ARI) is a major cause of
illness and death worldwide (1). Although ARI is the
third most common cause of death overall, in children it is
the major cause of death outside the neonatal period; an
estimated 2 million deaths occur in children <5 years of
age, predominantly in developing countries (2). Viruses
are a cause of upper and lower respiratory tract infections
in children and several of them have been described.
Among these, respiratory syncytial virus (RSV) is most
important, both in terms of prevalence and effect (3).
However, in recent years, several new viruses have
emerged. These include human metapneumovirus (4),
severe acute respiratory syndrome coronavirus (5) and
human coronaviruses HKU1 and NL63 (6,7). 
In 2005, Allander et al. reported detection of a new
human parvovirus that they named human bocavirus
(HBoV) (8). They detected this virus by constructing
libraries of amplified DNA and RNA from supernatants of
nasopharyngeal aspirates of children with ARI and remov-
ing nonviral nucleic acids by ultracentrifugation, microfil-
tration, and treatment with DNase. From this analysis, a
novel parvovirus sequence was obtained. The complete
genome sequence was determined and HBoV was charac-
terized. The only other related bocaviruses are bovine par-
vovirus and canine parvovirus 1 (CPV-1). APCR detection
method was devised that targeted the noncapsid protein-1
(NP-1) gene, and virus was detected in 24 (3%) of 806
children with ARI in Sweden. We used the same PCR
detection method to determine whether HBoV is a poten-
tial cause of ARI in children in Jordan.
The Study
From December 2003 to May 2004, all children <5
years of age admitted to the pediatric wards of King
Hussein Medical Centre (KHMC) and Queen Alia
Hospital (QAH) in Amman, Jordan, were enrolled into the
study after informed consent was obtained from parents or
guardians. The study, which determined the etiology,
inflammatory responses, and clinical effects of ARI was
approved by the research ethical approval committee of the
Royal Medical Services, Amman, Jordan. KHMC and
QAH provide all hospital pediatric care for Amman and its
surroundings. 
Diagnosis of ARI and assessment of its severity was
made by using World Health Organization (WHO) stan-
dard protocol for ARI based on the presence of cough,
tachypnea, chest indrawing, and wheezing for <7 days (9).
Severe disease was defined in children with a respiratory
rate >60/minute and chest indrawing. Oxygen saturation
(pO2) was measured by using pulse oximetry (Nellor,
Puritan Bennet, UK), and a pO2 <85% was used as the cut-
off for giving supplementary oxygen. Nasopharyngeal
aspirates (NPAs) were collected by instilling 1 mL sterile
phosphate-buffered saline through a nasopharyngeal
mucous extractor. The aspirate was frozen at −80°C and
transported frozen to Liverpool for analysis. 
DNA and RNA were extracted from aspirates by using
commercial kits (Qiagen, Basingstoke, UK). PCR or
reverse transcription PCR (RT-PCR) detection of influen-
za A and B viruses, parainfluenza virus 1–4 (10), human
metapneumovirus, RSV (11), adenovirus, Chlamydia spp.,
and Mycoplasma pneumoniae (12) was performed accord-
ing to previously published protocols. HBoV primers 188F
(5′-GAGCTCTGTAAGTACTATTAC-3′) and 542 R (5′-
CTCTGTGTTGACTGAATACAG-3′) that target the NP-1
protein gene and produce a 354-bp amplicon were used as
described and modified by Allander et al. (8). Other poten-
tial respiratory pathogens such as rhinoviruses and coron-
aviruses were not investigated because they are associated
primarily with upper respiratory infections.
A total of 326 children were enrolled in the study, but
sufficient nucleic acid was extractable from 312 NPAs for
detection of each potential respiratory pathogen. For the
remainder, the volume of NPAwas too small for extraction
of both DNAand RNAOf these, 57 (18.3%) children were
infected with HBoV (Table). The median age of HBoV-
infected patients was 8 months and 29 (51%) were male,
compared with a median age of 6 months and 156 (61%)
male patients in the HBoV-negative patients (p>0.2).
HBoV was detected in 30 (21.7%) of 138 children with
severe ARI and in 27 (15.5%) of 174 children with mild-
to-moderate ARI (p>0.2). However, only HBoV was
detected in 13 (48%) of the 27 patients with mild-to-mod-
erate ARI and with adenovirus (10 patients), RSV (2
DISPATCHES
1418 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 9, September 2006
*University of Liverpool, Liverpool, United Kingdom; and †King
Hussein Medical Centre, Amman, Jordanpatients) Chlamydia spp. (1 patient), and RSV and aden-
ovirus (1 patient) in the 14 remaining patients with mild-
to-moderate disease. In patients with severe ARI in whom
HBoV was detected, it was the only pathogen in 3 (10%)
patients. In the remaining 27 cases, it was found as a mixed
infection with RSV (9 patients), RSV and adenovirus (8
patients), RSV and Chlamydia spp. (2 patients), RSV and
influenza A virus (1 patient), HMPV and Chlamydia spp.
(1 patient) and adenovirus (6 patients). The median age
was 3.5 months for those infected only with HBoV and 10
months (p = 0.012) for those co-infected with HBoV and
other potential pathogens. 
Direct sequencing (Lark Technologies, Essex, UK) was
undertaken for 14 (25%) of the amplicons. Four amplicons
had the same sequence as the original Swedish strain. Five
variants were detected. One cluster (DNA Data Bank of
Japan accession no. AB243566 available from
www.ddbj.nig.ac.jp) contained 5 strains with mutations at
codons 21 (R→K) and 59 (S→N). Another cluster (AB
243570) contained 2 strains with 1 mutation at codon 79
(S→N). Three other variants were detected with changes at
codons 26 (R→K), 29 (Q→R), and 59 (S→N)
(AB243568), codons 21 (R→K) and 79 (S→N)
(AB243569), and codon 42 (R→Q) (AB243567), respec-
tively. No connections were found between patients with
different variants except for AB243570, in which 2 strains
were isolated from 2 children at the same orphanage in
Amman who came to the hospital on the same day. One had
mild-to moderate-disease, and the other had severe disease.
Conclusions
We detected HBoV in 57 (18.3%) of 312 children with
ARI severe enough to require hospital admission. HBoV
was detected in 30 (21.7%) of those admitted who were
classified according to WHO criteria as having severe
ARI. Other reported prevalences are 24 (3%) of 806 pedi-
atric samples in Sweden (8), 18 (5.6%) of 324 children <3
years of age in Australia (6), and 18 (5.7%) of 318 children
<3 years of age in Japan (13). These data support an asso-
ciation between the virus and ARI. 
As in the Australian study (6), mixed infections were
common. In the Australian study, HBoV was detected with
other potential respiratory pathogens in ≈56% of patients.
In our study, the prevalence (72%) of mixed infection was
even higher, occurring most often as a co-infection with
RSV. HBoV was found as sole pathogen in 2% of cases of
severe ARI and in 7.5% of mild-to-moderate ARI. 
This study was conducted during the peak period of
ARI in Jordan, and the prevalence of detection of HBoV
ranged from 12.9% in March to 37% in April. However,
larger cross-sectional studies and longitudinal studies of
HBoV-infected children are needed to determine whether
HBoV causes ARI, its effect on children, and its seasonal-
ity. In addition, HBoV, similar to some adenoviruses (14)
and other human parvoviruses, may show persistent shed-
ding after an initial acute infection.
Finally, we have also obtained evidence for variations
in the HBoV NP-1 gene. In addition to the original
Swedish strain, we found 5 variants with point mutations
in the gene causing amino acid substitution in the deduced
protein. What role this might play in HBoV pathogenesis
and whether other genes encoding nonstructural protein 1
(NS-1) and virion proteins 1/2 (VP1/2) show similar vari-
ability are unclear. However, 2 CPV-1 strains showed
96.5%, 92.5%, and 97.5% homology in their NS-1-, NP-
1-, and VP1/2-deduced proteins (15). 
Dr Kaplan is a consultant medical microbiologist at the King
Hussein Medical Centre in Amman, Jordan. His research interest
is childhood acute respiratory tract infections.
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